Table IV.
No Fatigue (n = 8) |
Fatigue (n = 39) |
||||
---|---|---|---|---|---|
Mean rank | Median | Mean rank | Median | ||
Fatigue score | Baseline | 2.00 | 42.00 | 18.12 | 47.00 |
Midpoint | 2.00 | 36.00 | 10.71 | 40.00 | |
Wilcoxon signed rank test | 0.564 | 0.000** | |||
GDNF concentration | Baseline | 3.50 | 0.13 | 20.66 | 0.14 |
Midpoint | 3.50 | 0.12 | 16.09 | 0.14 | |
Wilcoxon signed rank test | 0.463 | 0.350 | |||
BDNF concentration | Baseline | 7.50 | 0.94 | 22.35 | 0.84 |
Midpoint | 3.50 | 0.73 | 15.31 | 0.82 | |
Wilcoxon signed rank test | 0.674 | 0.008** | |||
SNAPIN concentration | Baseline | 5.50 | 19.72 | 20.35 | 20.29 |
Midpoint | 4.17 | 21.91 | 18.56 | 10.66 | |
Wilcoxon signed rank test | 0.327 | 0.597 |
Significant difference in fatigue scores and concentrations of glial cell-derived neurotrophic factor (GDNF), brain-derived neurotrophic factor (BDNF), and SNARE-associated protein (SNAPIN) between study time points are indicated by p values using Wilcoxon signed rank test (**P < 0.01).